Papers
4
Total Citations
14
H-Index
3
About
Davide Perri is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for complex urologic cancers and benign prostatic hyperplasia. His major contributions lie in refining robot-assisted radical cystectomy (RARC) for bladder cancer, particularly in challenging populations such as female patients undergoing neobladder diversion and those with pT4a disease. In a comparative study of 212 patients, he demonstrated that RARC offers favorable perioperative outcomes versus open surgery for advanced bladder cancer. Perri has also pioneered functional preservation in benign prostatic hyperplasia, comparing thulium laser enucleation (ThuLEP) to robot-assisted simple prostatectomy for very large prostates (≥150 ml). His innovative work in renal surgery includes a novel technique combining indocyanine green-marked fluorescence guidance with off-clamp robotic partial nephrectomy, showing improved surgical precision. With multiple papers accumulating citations within their first year of publication, Perri’s research is rapidly shaping clinical practice. His work consistently emphasizes safety, functional outcomes, and the expansion of robotic surgery’s role in urologic oncology and reconstruction.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4